“…Interestingly, an important function of BCL-2 is to antagonize the pro-apoptotic effect of BAX through direct interaction at this BH2 domain (Oltvai et al, 1993;Gross et al, 1999;Cheng et al, 2001), which is missing in both Dpl and mutated neurotoxic forms of PrP: DPrP (Shmerling et al, 1998;Flechsig et al, 2003;Li et al, 2007) and Tg(PG14)PrP (Chiesa et al, 1998). Indeed, fusion of Dpl to a BH2-containing octapeptide repeat and the N-terminal half of hydrophobic region of PrP c confer resistance to serum deprivation (Lee et al, 2006). Interestingly, N-terminally deleted forms of PrP c have been recently shown to activate both Bax-dependent and Bax-independent apoptotic pathways (Li et al, 2007).…”